Having worked on clinical trials for many
years, Dr. Ari Kiev envisioned a research institute dedicated to
finding safer and faster acting medications, while producing fewer
side effects. With this vision in mind, Dr. Kiev founded the Social
Psychiatry Research Institute in 1970 in order to conduct some of
the earliest clinical trials for new medications for depression
and anxiety. Over the past thirty five years SPRI has been integral
in researching many new medications that have been developed for
psychiatry. Over time, SPRI expanded beyond New York City, organizing
and managing clinical trials in Europe and India, with future plans
to help with the development of clinical trials in China as well.
Ari Kiev, M.D. is the founder and President of SPRI Clinical Trials.
Dr. Kiev is a graduate of Harvard College, Cornell Medical College,
and New York Law School. He has been a pioneer in the field of psychopharmacology,
developing medications for psychiatry since 1964. Over the years,
Dr. Kiev has been involved in more than 250 clinical trials. Dr.
Kiev is the author of over 18 books, including the classics, A Strategy
for Daily Living and Recovery from Depression.
Nick Vatakis, M.D. is the Medical Director of
SPRI Clinical Trials. He has served on the teaching faculty at New York
University. He has participated in over 150 clinical trials for
the treatment of depression, anxiety, panic disorder, bipolar disorder,
schizophrenia, insomnia, fibromyalgia, PMDD, Alzheimer’s disease, stuttering and other
areas of mental health. He has consulted for numerous pharmaceutical
companies regarding protocol development and placebo response. He
also has a private practice where he treats patients utilizing psychopharmacology,
dynamic psychotherapy and coaching.
Our team consists of Clinical Research Coordinators who work closely
with the Principal Investigators on our studies. All of our staff
have backgrounds in psychology and medicine and are trained to follow
Good Clinical Practice guidelines and FDA regulations.